Endocrinology Practice Questions

Q: Which of the following is not a characteristic feature of Multiple Endocrine Neoplasia type 1 (MEN1)?

Posterior pituitary tumors. **Explanation:** Multiple Endocrine Neoplasia type 1 (MEN1), also known as **Wermer’s Syndrome**, is an autosomal dominant disorder caused by a mutation in the *MEN1* gene (encoding the protein Menin). It is classically characterized by the **"3 Ps"**: Parathyroid, Pancreas, and Pituitary. **Why Option A is correct:** While pituitary adenomas are a hallmark of MEN1, they almost exclusively involve the **Anterior Pituitary** (adenohypophysis). Prolactinomas are the most common, followed by somatotropinomas (GH-secreting). The **Posterior Pituitary** (neurohypophysis) is not involved in the MEN1 syndrome, making this the "except" or incorrect feature. **Why other options are incorrect:** * **B. Foregut Carcinoids:** These are recognized components of MEN1. They include thymic, bronchial, and gastric carcinoids. Thymic carcinoids are particularly aggressive and are a significant cause of mortality in these patients. * **C. Parathyroid Hyperplasia:** This is the **most common** (95% of patients) and usually the earliest clinical manifestation of MEN1. It typically involves multiglandular hyperplasia rather than a single adenoma. * **D. Pancreatic Neuroendocrine Tumors (pNETs):** These occur in about 60-70% of patients. Gastrinomas (leading to Zollinger-Ellison Syndrome) are the most common symptomatic pNET, followed by Insulinomas. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Autosomal Dominant; Chromosome **11q13**. * **Most common feature:** Primary Hyperparathyroidism. * **Most common pituitary tumor:** Prolactinoma. * **Cutaneous markers:** Angiofibromas, collagenomas, and lipomas are frequently seen and can aid in early clinical diagnosis. * **Screening:** Annual biochemical screening (Calcium, PTH, Gastrin, Prolactin) is recommended for carriers starting in childhood.

Q: Which statement is not true regarding hypocalcemia?

Inverse relation with magnesium levels. ### Explanation **1. Why Option D is the Correct Answer (The False Statement)** The relationship between magnesium and calcium is **direct**, not inverse. Magnesium is essential for the synthesis and release of Parathyroid Hormone (PTH) and for the responsiveness of target organs to PTH [1]. * **Hypomagnesemia** leads to functional hypoparathyroidism, causing **hypocalcemia** [1]. * Severe magnesium deficiency inhibits PTH secretion and induces PTH resistance. Therefore, to correct hypocalcemia in such patients, magnesium must be replenished first [1]. **2. Analysis of Incorrect Options (True Statements)** * **Option A (Hypoparathyroidism):** This is the most common cause of hypocalcemia. PTH is the primary hormone responsible for increasing serum calcium; its deficiency leads to decreased bone resorption and renal calcium reabsorption [1], [2]. * **Option B (Latent Tetany):** Hypocalcemia increases neuromuscular excitability. Latent tetany refers to neuromuscular irritability that is not clinically apparent but can be elicited by provocative tests like **Chvostek’s sign** (facial twitching) and **Trousseau’s sign** (carpal spasm). * **Option C (Prolonged QT Interval):** On ECG, hypocalcemia characteristically causes prolongation of the ST segment, which leads to a **prolonged QT interval** [1]. This is a high-yield diagnostic marker. **3. Clinical Pearls for NEET-PG** * **Trousseau’s Sign** is more specific for hypocalcemia than Chvostek’s sign. * **Hungry Bone Syndrome:** Severe hypocalcemia seen post-parathyroidectomy or thyroidectomy. * **Correction Formula:** For every 1 g/dL drop in serum albumin below 4 g/dL, add 0.8 mg/dL to the measured calcium level to get the **Corrected Calcium** [1]. * **Hyperphosphatemia** is typically seen in hypoparathyroidism, whereas **hypophosphatemia** is seen in Vitamin D deficiency [1].

Q: A 50-year-old man reports experiencing transient episodes of rapid heart beat accompanied by sweating, flushing, and a sense of impending doom. Physical examination is normal, with no evidence of arrhythmia during the examination. During one of these episodes, his wife, a nurse, documented a blood pressure of 195/140 mmHg and a heart rate of 160 beats/min. The episode resolved before he could be evaluated. Which of the following urinary measurements would be most useful for diagnosis?

Vanillylmandelic acid (VMA). ### Explanation **Diagnosis: Pheochromocytoma** The clinical presentation of paroxysmal hypertension, tachycardia, diaphoresis, flushing, and a "sense of impending doom" (panic-like symptoms) is a classic triad for **Pheochromocytoma**. This is a catecholamine-secreting tumor arising from chromaffin cells of the adrenal medulla. **1. Why Vanillylmandelic acid (VMA) is the correct answer:** Catecholamines (epinephrine and norepinephrine) are metabolized into metanephrines and subsequently into **Vanillylmandelic acid (VMA)** [1]. In a patient with episodic hypertension, measuring the 24-hour urinary excretion of VMA or metanephrines is a standard biochemical screening tool [1]. VMA is the end-stage metabolite excreted in the urine, making it a highly specific marker for catecholamine excess [1]. **2. Why the other options are incorrect:** * **A. DHEA:** An androgen precursor produced by the adrenal cortex [2]. It is used to evaluate adrenal tumors causing virilization, not paroxysmal hypertension. * **B. hCG:** A hormone produced during pregnancy or by certain germ cell tumors; it has no relevance to sympathetic overactivity. * **C. 17-ketosteroids:** These are metabolites of androgens (like DHEA and androstenedione) [2]. They are used to assess adrenal cortical function, not the adrenal medulla. **3. NEET-PG High-Yield Pearls:** * **Rule of 10s:** 10% are bilateral, 10% are extra-adrenal (Paragangliomas), 10% are malignant, and 10% occur in children. * **Best Initial Test:** Plasma free metanephrines (highest sensitivity). * **Confirmatory Test:** 24-hour urinary metanephrines and VMA (highest specificity). * **Pre-operative Management:** Always give **Alpha-blockers first** (e.g., Phenoxybenzamine) followed by Beta-blockers. Giving a Beta-blocker first can lead to an unopposed alpha-adrenergic crisis. * **Associated Syndromes:** MEN 2A, MEN 2B, von Hippel-Lindau (VHL), and NF-1 [1].

Q: What is the drug of choice for acute adrenal insufficiency?

IV hydrocortisone. Explanation: Acute adrenal insufficiency (Adrenal Crisis) is a medical emergency characterized by a severe deficiency of cortisol and, often, aldosterone. The primary goal of treatment is rapid replacement of glucocorticoids and volume resuscitation. Why IV Hydrocortisone is the Correct Answer: Hydrocortisone is the drug of choice because it possesses both glucocorticoid and mineralocorticoid activity in a 1:1 ratio. In an acute crisis, the patient lacks both hormones; hydrocortisone effectively replaces cortisol while providing sufficient sodium-retaining (aldosterone-like) effects at high doses (usually 100mg IV bolus followed by 200mg/24h). Its rapid onset and balanced profile make it the gold standard. Analysis of Incorrect Options: * A. Oral Prednisone: In an acute crisis, patients are often hemodynamically unstable, vomiting, or obtunded. Oral administration is unreliable and too slow for emergency stabilization. * C. IV Betamethasone: This is a potent long-acting glucocorticoid with zero mineralocorticoid activity. It is primarily used for fetal lung maturity, not adrenal replacement. * D. IV Dexamethasone: While dexamethasone is potent, it lacks mineralocorticoid activity. It is only preferred if a Short Synacthen (ACTH) test needs to be performed immediately, as dexamethasone does not cross-react with cortisol assays, unlike hydrocortisone [1]. High-Yield Clinical Pearls for NEET-PG: * Initial Management: Start IV fluids (Normal Saline) and IV Hydrocortisone immediately; do not wait for laboratory confirmation if the clinical suspicion is high [1]. * Electrolyte Pattern: Look for Hyponatremia, Hyperkalemia, and Hypoglycemia in the question stem. * Maintenance: Once the patient is stable, mineralocorticoid replacement (Fludrocortisone) is added only when the hydrocortisone dose is tapered below 50mg/day.

Q: A 50-year-old man with a history of type 2 diabetes mellitus asks about the chances that his children will inherit this metabolic disorder. The patient is told that he has a genetic disease that shows which of the following patterns of inheritance?

Multifactorial. **Explanation:** **1. Why Multifactorial is Correct:** Type 2 Diabetes Mellitus (T2DM) is a classic example of a **multifactorial (polygenic) inheritance** pattern [1]. Unlike monogenic disorders, T2DM results from the complex interplay between **multiple susceptibility genes** and **environmental factors** (such as obesity, sedentary lifestyle, and diet) [1]. While T2DM has a stronger genetic component than Type 1 DM—with a concordance rate of 70-90% in monozygotic twins—it does not follow a simple Mendelian pattern. If one parent has T2DM, the risk to the offspring is approximately 15-40%. **2. Why Other Options are Incorrect:** * **Autosomal Dominant (AD):** While **MODY** (Maturity-Onset Diabetes of the Young) follows an AD pattern due to single-gene mutations (e.g., HNF1-alpha, Glucokinase), it represents only 1-5% of diabetes cases and is distinct from common T2DM. * **Autosomal Recessive (AR):** AR inheritance requires two copies of a mutated gene. T2DM risk is cumulative across many loci and influenced by lifestyle, making this pattern inapplicable. * **X-linked Dominant:** This would involve a specific inheritance pattern linked to the X chromosome (e.g., Alport syndrome), which is not observed in the epidemiology of T2DM. **3. High-Yield Clinical Pearls for NEET-PG:** * **Genetic Risk:** If both parents have T2DM, the risk to offspring increases to nearly **60-75%**. * **Twin Concordance:** Monozygotic twins (70-90%) vs. Dizygotic twins (20-30%). * **HLA Association:** T2DM has **no** strong association with HLA markers, unlike Type 1 DM (associated with HLA-DR3 and DR4) [2]. * **MODY vs. T2DM:** Always look for "strong family history in 3 consecutive generations" and "young age of onset (<25 years)" to differentiate MODY (AD) from T2DM (Multifactorial).

Q: What is the most useful investigation in the diagnosis of diabetic ketoacidosis?

Ketonemia. Diabetic Ketoacidosis (DKA) is defined by the biochemical triad of **hyperglycemia, ketosis, and metabolic acidosis**. While all these components are necessary for diagnosis, **ketonemia** (specifically the measurement of serum beta-hydroxybutyrate) is the most useful and definitive investigation for confirming the diagnosis and monitoring treatment. [1] * **Why Ketonemia is correct:** Beta-hydroxybutyrate (β-OHB) is the predominant ketone body in DKA. Serum testing is more sensitive and specific than urine testing. It provides a real-time reflection of the metabolic state, as it rises earliest during onset and falls rapidly with effective insulin therapy. * **Why pH of blood is incorrect:** While a low pH (acidosis) is a hallmark of DKA, it is non-specific. Acidosis can occur in many other conditions (e.g., lactic acidosis, uremia, or sepsis) without the presence of ketones. * **Why Urinary sugar is incorrect:** Glucosuria simply indicates that the blood glucose has exceeded the renal threshold (~180 mg/dL). It does not differentiate between simple hyperglycemia and life-threatening DKA. * **Why Urine ketone is incorrect:** Urine tests use the nitroprusside reaction, which detects **acetoacetate** but not β-OHB. In early DKA, the ratio of β-OHB to acetoacetate is high (up to 10:1), meaning urine tests can yield a **false negative** or underestimate the severity of ketosis. **Clinical Pearls for NEET-PG:** * **Diagnostic Criteria:** Blood glucose >250 mg/dL, pH <7.3, Bicarbonate <18 mEq/L, and positive ketones [1]. * **Best Marker for Monitoring:** Serum beta-hydroxybutyrate is the preferred marker to track the resolution of DKA. [2] * **Anion Gap:** DKA is a classic cause of **High Anion Gap Metabolic Acidosis (HAGMA)**. * **Management Priority:** The first step in management is always **aggressive fluid resuscitation** (Normal Saline), followed by insulin infusion and potassium correction. [1]

Q: High calcium intake can lead to which of the following conditions?

Milk alkali syndrome. **Explanation:** **Milk-Alkali Syndrome (MAS)** is the correct answer. It is a clinical triad of **hypercalcemia, metabolic alkalosis, and acute kidney injury** caused by the excessive ingestion of calcium (usually as calcium carbonate) and absorbable alkali [2]. 1. **Mechanism:** High intake of calcium carbonate leads to hypercalcemia. Hypercalcemia causes renal vasoconstriction and inhibits the Na-K-2Cl cotransporter (inducing natriuresis and volume depletion). This volume depletion stimulates bicarbonate reabsorption, leading to metabolic alkalosis [3]. Alkalosis, in turn, enhances calcium reabsorption in the distal tubule, creating a vicious cycle that further elevates serum calcium levels. **Analysis of Incorrect Options:** * **A. Osteoporosis:** This is characterized by low bone mineral density. High calcium intake is actually a preventive measure or adjunct treatment for osteoporosis, not a cause [1]. * **B. Osteopetrosis:** This is a rare genetic "marble bone" disease caused by defective osteoclast function, leading to overly dense but brittle bones. It is not caused by dietary calcium intake. * **D. Renal Failure:** While MAS can *lead* to renal failure (as part of the triad), "Renal failure" as a standalone option is less specific than the syndrome itself. In the context of high calcium/alkali intake, MAS is the primary diagnosis [2]. **NEET-PG High-Yield Pearls:** * **Modern Etiology:** Historically caused by milk/antacids for peptic ulcers; currently, the most common cause is over-the-counter **calcium carbonate** supplements used for osteoporosis prevention. * **Clinical Presentation:** Patients may present with confusion, polyuria, polydipsia, and vomiting. * **ECG Finding:** Hypercalcemia typically causes a **shortened QT interval**. * **Treatment:** Aggressive hydration with isotonic saline and discontinuation of the offending agents.

Question 1

Which of the following is not a characteristic feature of Multiple Endocrine Neoplasia type 1 (MEN1)?

Accepted Answer

Posterior pituitary tumors

Answer

Foregut carcinoids

Answer

Parathyroid hyperplasia

Answer

Pancreatic neuroendocrine tumors

Question 2

A 53-year-old man with gout, experiencing 4-5 attacks per year and treated with NSAIDs without prophylaxis, presents with tophaceous deposits on his left hand. Screening for renal complications of chronic gout is performed. Which of the following findings is most likely compatible with chronic gouty nephropathy?

Accepted Answer

Decreased urinary concentrating ability and proteinuria

Answer

Nephrotic syndrome

Answer

Acute kidney injury

Answer

Acute tubular necrosis (ATN)

Question 3

Which statement is not true regarding hypocalcemia?

Accepted Answer

Inverse relation with magnesium levels

Answer

Can occur in hypoparathyroidism

Answer

Latent tetany is seen

Answer

Prolonged QT interval is seen

Question 4

A 50-year-old man reports experiencing transient episodes of rapid heart beat accompanied by sweating, flushing, and a sense of impending doom. Physical examination is normal, with no evidence of arrhythmia during the examination. During one of these episodes, his wife, a nurse, documented a blood pressure of 195/140 mmHg and a heart rate of 160 beats/min. The episode resolved before he could be evaluated. Which of the following urinary measurements would be most useful for diagnosis?

Accepted Answer

Vanillylmandelic acid (VMA)

Answer

Dehydroepiandrosterone (DHEA)

Answer

Human chorionic gonadotropin (hCG)

Answer

17-ketosteroids

Question 5

What is the drug of choice for acute adrenal insufficiency?

Accepted Answer

IV hydrocortisone

Answer

Oral prednisone

Answer

IV betamethasone

Answer

IV dexamethasone

Question 6

A 40-year-old woman has experienced increasingly frequent episodes of weakness accompanied by numbness and tingling in her hands and feet for the past year. On examination, her blood pressure is 168/112 mm Hg. Laboratory studies show sodium, 142 mmol/L; potassium, 2.9 mmol/L; chloride, 104 mmol/L; HCO3-, 28 mmol/L; and glucose, 74 mg/dL. Her plasma renin activity is low. Which of the following radiologic findings is most likely to be present in this woman?

Accepted Answer

Adrenal nodular enlargement

Answer

Pancreatic mass

Answer

Retroperitoneal mass

Answer

Thyroid nodular enlargement

Question 7

A 50-year-old man with a history of type 2 diabetes mellitus asks about the chances that his children will inherit this metabolic disorder. The patient is told that he has a genetic disease that shows which of the following patterns of inheritance?

Accepted Answer

Multifactorial

Answer

Autosomal dominant

Answer

Autosomal recessive

Answer

X-linked dominant

Question 8

What is the most useful investigation in the diagnosis of diabetic ketoacidosis?

Accepted Answer

Ketonemia

Answer

pH of blood

Answer

Urinary sugar

Answer

Urine ketone

Question 9

A young female presents with hypertension and VMA > 14 mg/day. Which of the following conditions are associated with this presentation?

Accepted Answer

Medullary carcinoma of the thyroid, Von Hippel-Lindau disease, Grave's disease, Neurofibromatosis

Answer

Medullary carcinoma of the thyroid, Von Hippel-Lindau disease, Sturge-Weber syndrome, Grave's disease

Answer

Medullary carcinoma of the thyroid, Von Hippel-Lindau disease, Sturge-Weber syndrome, Neurofibromatosis

Answer

Medullary carcinoma of the thyroid, Sturge-Weber syndrome, Grave's disease, Neurofibromatosis

Question 10

High calcium intake can lead to which of the following conditions?

Accepted Answer

Milk alkali syndrome

Answer

Osteoporosis

Answer

Osteopetrosis

Answer

Renal failure

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?